Free Access
Med Sci (Paris)
Volume 24, Number 2, Février 2008
Page(s) 139 - 141
Section Nouvelles
Published online 15 February 2008
  1. Finch CA, Sturgeon P. Erythrokinetics in Cooley’s anemia. Blood 1957; 12 : 64–73. [Google Scholar]
  2. Fessas P. Inclusions of hemoglobin erythroblasts and erythrocytes of thalassemia. Blood 1963; 21 : 21–32. [Google Scholar]
  3. Hershko C, Graham G, Bates GW, Rachmilewitz EA. Non-specific serum iron in thalassaemia : an abnormal serum iron fraction of potential toxicity. Br J Haematol 1978; 40 : 255–63. [Google Scholar]
  4. Hershko C, Weatherall DJ. Iron-chelating therapy. Crit Rev Clin Lab Sci 1988; 26 : 303–45. [Google Scholar]
  5. Pootrakul P, Sirankapracha P, Hemsorach S, et al. A correlation of erythrokinetics, ineffective erythropoiesis, and erythroid precursor apoptosis in thai patients with thalassemia. Blood 2000; 96 : 2606–12. [Google Scholar]
  6. Centis F, Tabellini L, Lucarelli G, et al. The importance of erythroid expansion in determining the extent of apoptosis in erythroid precursors in patients with beta-thalassemia major. Blood 2000; 96 : 3624–9. [Google Scholar]
  7. Schrier SL, Centis F, Verneris M, et al. The role of oxidant injury in the pathophysiology of human thalassemias. Redox Rep 2003; 8 : 241–5. [Google Scholar]
  8. Papanikolaou G, Tzilianos M, Christakis JI, et al. Hepcidin in iron overload disorders. Blood 2005; 105 : 4103–5. [Google Scholar]
  9. Origa R, Galanello R, Ganz T, et al. Liver iron concentrations and urinary hepcidin in beta-thalassemia. Haematologica 2007; 92 : 583–8. [Google Scholar]
  10. Ganz T. Defensins and other antimicrobial peptides : a historical perspective and an update. Comb Chem High Throughput Screen 2005; 8 : 209–17. [Google Scholar]
  11. Nicolas G, Vaulont S. Le mécanisme d’action de l’hepcidine déchiffré. Med Sci (Paris) 2005; 21 : 7–9. [Google Scholar]
  12. Fleming RE. Advances in understanding the molecular basis for the regulation of dietary iron absorption. Curr Opin Gastroenterol 2005; 21 : 201–6. [Google Scholar]
  13. Tanno T, Bhanu NV, Oneal PA, et al. High levels of GDF15 in thalassemia suppress expression of the iron regulatory protein hepcidin. Nat Med 2007; 13 : 1096–101. [Google Scholar]
  14. Peyssonnaux C, Zinkernagel AS, Schuepbach RA, et al. Regulation of iron homeostasis by the hypoxia-inducible transcription factors (HIFs). J Clin Invest 2007; 117 : 1926–32. [Google Scholar]
  15. Xu J, Kimball TR, Lorenz JN, et al. GDF15/MIC-1 functions as a protective and antihypertrophic factor released from the myocardium in association with SMAD protein activation. Circ Res 2006; 98 : 342–50. [Google Scholar]
  16. Babitt JL, Huang FW, Xia Y, et al. Modulation of bone morphogenetic protein signaling in vivo regulates systemic iron balance. J Clin Invest 2007; 117 : 1933–9. [Google Scholar]
  17. Truksa J, Peng H, Lee P, Beutler E. Bone morphogenetic proteins 2, 4, and 9 stimulate murine hepcidin 1 expression independently of Hfe, transferrin receptor 2 (Tfr2), and IL-6. Proc Natl Acad Sci USA 2006; 103 : 10289–93. [Google Scholar]
  18. Beaumont C. Mécanismes moléculaires de l’homéostasie du fer. Med Sci (Paris) 2004; 20 : 68–72 [Google Scholar]
  19. Peyssonnaux C. Les facteurs de transcription HIF : régulateurs clés du métabolisme du fer ? Med Sci (Paris) 2008; 24 : 137–8. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.